Home/Filings/4/0001567619-21-022229
4//SEC Filing

PLATZER ERICH 4

Accession 0001567619-21-022229

CIK 0000882361other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 1:45 PM ET

Size

10.6 KB

Accession

0001567619-21-022229

Insider Transaction Report

Form 4
Period: 2021-12-15
Transactions
  • Purchase

    Common Shares

    2021-12-15$1.19/sh+30,000$35,700305,000 total
  • Purchase

    Common Shares

    2021-12-15$1.18/sh+100,000$117,600405,000 total
  • Purchase

    Common Shares

    2021-12-15$1.16/sh+120,000$139,080255,000 total
  • Purchase

    Common Shares

    2021-12-15$1.20/sh+20,000$23,960275,000 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.115 to $1.19, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.195 to $1.20, inclusive. The reporting person undertakes to provide to Aptose Biosciences, Inc., any security holder of Aptose Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.155 to $1.20, inclusive. The reporting person undertakes to provide to Aptose Biosciences, Inc., any security holder of Aptose Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001275087

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 1:45 PM ET
Size
10.6 KB